SCHEMBL21459319

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL6929568	0.79	—	—
	Bromide SCHEMBL1161612	0.77	NOTUM (0.42)	ALDH1A1TSHRNSD2ABL1PPARG
	SCHEMBL885378	0.77	—	—
	SCHEMBL13660763	0.73	GPR84 (0.43)	TSHRNSD2ABL1PPARGRIN1
	SCHEMBL9494732	0.72	—	—
	SCHEMBL9686886	0.72	—	—
	SCHEMBL29183551	0.72	—	—
	SCHEMBL1161397	0.72	—	—
	SCHEMBL22624852	0.72	ABL1 (0.39)	NSD2ABL1PPARGRIN1L3MBTL1
	SCHEMBL16885240	0.72	MEN1 (0.46)	TSHRNSD2ABL1PPARGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.